Publications by authors named "Evren Kaynak"
Background: Transcatheter aortic valve replacement (TAVR) has evolved as a breakthrough therapy for patients with severe aortic valve stenosis. While TAVR has revolutionized the management of aortic valve disease, the procedure may be associated with the development of conduction disturbances requiring permanent pacemaker implantation. Traditionally, conventional transvenous pacemakers have been used to address these complications.
View Article and Find Full Text PDFBackground: Prosthetic valve thrombosis during pregnancy is life-threatening for mother and fetus, and the treatment of this complication is unclear. Cardiac surgery in pregnancy is associated with very high maternal and fetal mortality and morbidity. Thrombolytic therapy has rarely been used in these patients.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to find the safest and most effective thrombolytic treatment for patients with prosthetic valve thrombosis, analyzing different treatment regimens over a 16-year period.
- Out of 182 patients treated, the overall success rate was 83.2%, with no significant difference in effectiveness among the various treatment groups; however, Group V (low-dose t-PA) had significantly lower complication rates.
- Key predictors of complications included the type of thrombolytic therapy used and a history of stroke, highlighting Group V as the safest option in terms of both mortality and nonfatal major complications.
Myocardial infarction (MI) due to acute obstruction of the left main coronary artery (LMCA) occlusion is a medical emergency, requiring early and prompt diagnosis and revascularization, and unless it is treated, it will frequently result in cardiogenic shock, which has a high fatality rate. Our case focused on a patient, who was transferred to our hospital relatively late due to peculiar ECG. He had acute MI, and was in cardiogenic shock.
View Article and Find Full Text PDFPatients who have dialysis-dependent renal disease frequently present with coronary artery disease but are considered at high risk for coronary artery bypass grafting. From 1 September 2000 through 31 August 2003, we performed complete off-pump coronary revascularization in 6 patients who had end-stage dialysis-dependent renal failure, and we prospectively studied the perioperative and early postoperative results. The effect of off-pump coronary artery bypass grafting on mortality, morbidity, postoperative complications, and transfusion requirements in this group of patients was investigated.
View Article and Find Full Text PDF